Prognosis of lung cancer patients with life-threatening complications

Chest

Volumn 131, Issue 3, 2007, Pages 840-846

  Soares, Márcio ^a   Darmon, Michael ^b   Salluh, Jorge I F ^a   Ferreira, Carlos G ^a   Thiéry, Guillaume ^b   Schlemmer, Benoit ^b   Spector, Nelson ^c   Azoulay, Élie ^b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Acute respiratory failure; Intensive care; Lung cancer; Mechanical ventilation; Outcome

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CANCER PATIENT; CARDIOVASCULAR DISEASE; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LARGE CELL CARCINOMA; LENGTH OF STAY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NEUROLOGICAL COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; SEPTIC SHOCK; TREATMENT OUTCOME;

EID: 33947419747     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-2244     Document Type: Article

References (36)

1. Bunn PA Jr, Shepherd FA, Sandler A, et al. Ongoing and future trials of biologic therapies in lung cancer. Lung Cancer 2003; 41(suppl):S175-S186
2. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 2002; 360:1131-1135
3. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005; 352:2589-2597
4. Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004; 22:1589-1597
5. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350:351-360
6. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005; 353:123-132
7. Sandler AB, Gray R, Brahmer J, et al. Randomized phase II/III trial of paclitaxel plus carboplatin with or without bevacizumab (NSC # 704865) in patients with advanced non-squamous non-small cell lung cancer: an Eastern Cooperative Oncology Group (ECOG) trial-E4599. J Clin Oncol 2005; 23(suppl 16):S4
8. Azoulay E, Alberti C, Bornstain C, et al. Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 2001; 29:519-525
9. Kress JP, Christenson J, Pohlman AS, et al. Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 1999; 160:1957-1961
10. Staudinger T, Stoiser B, Mullner M, et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 2000; 28:1322-1328
11. Ewer MS, Ali MK, Atta MS, et al. Outcome of lung cancer patients requiring mechanical ventilation for pulmonary failure. JAMA 1986; 256:3364-3366
12. Lin YC, Tsai YH, Huang CC, et al. Outcome of lung cancer patients with acute respiratory failure requiring mechanical ventilation. Respir Med 2004; 98:43-51
13. Piccirillo JF, Tierney RM, Costas I, et al. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004; 291:2441-2447
14. Boussat S, El'rini T, Dubiez A, et al. Predictive factors of death in primary lung cancer patients on admission to the intensive care unit. Intensive Care Med 2000; 26:1811-1816
15. Jennens RR, Rosenthal MA, Mitchell P, et al. Outcome of patients admitted to the intensive care unit with newly diagnosed small cell lung cancer. Lung Cancer 2002; 38:291-296
16. Reichner CA, Thompson JA, O'Brien S, et al. Outcome and code status of lung cancer patients admitted to the medical ICU. Chest 2006; 130:719-723
17. Soares M, Fontes F, Dantas J, et al. Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study. Critical Care 2004; 8:R194-R203
18. Thiery G, Azoulay E, Darmon M, et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005; 23:4406-4413
19. Le Gall J-R, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
20. Le Gall JR, Klar J, Lemeshow S, et al. The logistic organ dysfunction system: a new way to assess organ dysfunction in the intensive care unit; ICU Scoring Group. JAMA 1996; 276:802-810
21. Piccirillo JF. Adult Comorbidity Evaluation-27. Comorbidity data collection form, 2001. Available at: http://oto.wustl.edu/ clinepi/downloads. html. Accessed May 22, 2006
22. Zubrod CG, Schneiderman M, Frei E III, et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 1960; 11:7-33
23. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710-1717
24. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee; American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655
25. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-140
26. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-1754
27. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
28. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York, NY: Wiley-Interscience, 2000
29. Soares M, Salluh JI, Spector N, et al. Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for > 24 h. Crit Care Med 2005; 33:520-526
30. Soares M, Carvalho MS, Salluh JIF, et al. Effect of age on survival of critically ill patients with cancer. Crit Care Med 2006; 34:715-721
31. Groeger JS, Lemeshow S, Price K, et al. Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol 1998; 16:761-770
32. Hanley JA, McNeil BJ. The meaning and use of the area under receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36
33. Read WL, Tierney RM, Page NC, et al. Differential prognostic impact of Comorbidity. J Clin Oncol 2004; 22:3099-3103
34. Soares M, Salluh JI, Ferreira CG, et al. Impact of two different Comorbidity measures on the six-month mortality of critically ill cancer patients. Intensive Care Med 2005; 31: 408-415
35. Azoulay E, Thiery G, Chevret S, et al. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 2004; 83:360-370
36. Sarna L, Padilla G, Holmes C, et al. Quality of life of long-term survivors of non-small-cell lung cancer. J Clin Oncol 2002; 20:2920-2929